MedPath

ELIXOPHYLLIN

ELIXOPHYLLIN Elixir(Theophylline Oral Solution, USP)(brand of theophylline anhydrous)Rx Only

Approved
Approval ID

8328cefd-49aa-4621-a7c3-49a14a19cbe7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2018

Manufacturers
FDA

Carilion Materials Management

DUNS: 079239644

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

THEOPHYLLINE ANHYDROUS

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68151-0644
Application NumberANDA085186
Product Classification
M
Marketing Category
C73584
G
Generic Name
THEOPHYLLINE ANHYDROUS
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 29, 2016
FDA Product Classification

INGREDIENTS (7)

SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
THEOPHYLLINE ANHYDROUSActive
Quantity: 80 mg in 15 mL
Code: 0I55128JYK
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ELIXOPHYLLIN - FDA Drug Approval Details